Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-25

Clinical Trial Update: A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether omeprazole and famotidine affect the absorption of telotristat ethyl in healthy subjects; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)
  • Omeprazole (Omeprazole)
  • Telotristat Ethyl (telotristat ethyl)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Drug-drug Interaction | Phase 1 | Status: COMPLETED